North America leads the Sodium Citrate ESR Test Tube market, capturing 30% of global demand in 2023. Advanced healthcare infrastructure, high adoption of diagnostic technologies, and robust R&D investments in personalized medicine drive growth. Regulatory frameworks promoting quality standards further solidify its maturity. Meanwhile, Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 8.5% through 2030. Rising healthcare accessibility, a large patient pool, and government initiatives to modernize diagnostic facilities are accelerating adoption. Europe maintains a 25% market share, supported by aging demographics, stringent policies for blood disorder management, and well-established hospital networks. Latin America, at 10%, benefits from incremental healthcare infrastructure upgrades and partnerships with global diagnostics firms. The Middle East & Africa, holding 5%, is gaining traction due to growing private-sector investments and efforts to combat anemia and other conditions. Regional forecast models highlight Asia Pacificโs potential to surpass Europe by 2030, fueled by ecosystem maturity and demographic tailwinds.